Nancy Guillen, Ph.D.

Associate Director, Johnson and Johnson Innovative Medicines

Nancy Guillen, Ph.D. is listed as Associate Director, Johnson and Johnson Innovative Medicines. Nancy is scheduled to speak at BPI West 2027 on 18 March 2027.

Compiled from published conference agendas; not yet confirmed by Nancy. Is this you? Claim this profile.

Upcoming

BPI West 2027 16 March 2027 – 18 March 2027

• Integration of Experimental Execution, Statistics and Multivariate Data Analysis to Optimize Process Performance and Product Quality in the Production of Multispecific Antibody Therapies in CHO Cells Speaker · 18 March 2027